Form 8-K Akari Therapeutics Plc For: Mar 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Akari Therapeutcis (AKTX) Enters $1.615M Private Placement
March 11, 2024 5:26 PM EDTOn March 11, 2024, Akari Therapeutcis (NASDAQ: AKTX) entered into a definitive agreement (the Purchase Agreement) with certain existing investors, pursuant to which the Company agreed to sell and issue in a private placement (the Private Placement) approximately $1,615,000 of unregistered American Depository Shares (ADSs), each representing 2,000 of the Companys ordinary shares, at a to be determined purchase price per ADS equal to the lower of: (i) $1.57 (the product of 0.7 and the official closing price of the ADSs on The Nasdaq Stock Market (Nasdaq) on March 4, 2024, the trading day immediately preceding the public announcement of the Companys entry into... More
